Rayludwiczak,
You have been Chicken Little for years
Rayludwiczak,
You have been Chicken Little for years with your comments against NanoLogix. Your statement of "for as long as this company has been in business and indicating sales less than a million" demonstrates your lack of a grasp of reality for the diagnostic business and challenges faced by any company competing with BD, Thermo Fisher, and others. When was NanoLogix first incorporated? 1989 I believe. Did they sell product at all over their first incarnation? Not that I can find.
Jump ahead...
I remember NanoLogix coming out in mid-2012 with news that they were starting commercial sales. If they've gone from "no sales" to "sales of hundreds of thousands" but less that "a million" in the past 3-1/2 years that should impress people smart enough to understand what it takes to grow in a terrible market environment. Unfortunately it doesn't appear you're one who's able to understand.
Scott
8
3
Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Major Shareholder Notification from Morgan Stanley In accordance with the Danish Capital Markets Act, Svitzer Group A/S, recognized by CVR-no. 44 79 14 47, shares an important notification regarding its major shareholder. Morgan Stanley recently disclosed that as of a specified date, it directly or indirectly holds 1,642,654 shares in Svitzer Group. This corresponds to...
Continue Reading
Understanding Petco Health and Wellness Legal Challenges Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) has recently encountered significant legal challenges that may impact its investors. As a notable player in the pet health and wellness sector, Petco is dedicated to improving the lives of pets and their owners. However, the company is currently under scrutiny...
Continue Reading
Survey Reveals User Preferences for AI Interaction A recent survey conducted by Muah AI has shed light on user preferences, revealing a strong inclination towards uncensored large language models (LLMs). More than 85% of the 25,000 active respondents expressed a desire for less restrictive communication tools. This finding indicates a growing demand for more open and...
Continue Reading
Dyne Therapeutics Announces Presentations at Major Conference Dyne Therapeutics, Inc (NASDAQ: DYN), primarily known for its dedication to advancing therapeutics for neuromuscular diseases, is gearing up to showcase its innovative research at the upcoming MDA Clinical & Scientific Conference. This event is scheduled to take place from March 16-19, 2025, and will feature a...
Continue Reading
Strengthening the Fight Against Illegal Trade Public and private sector security experts have gathered to address the escalating threat of illegal trade and its impact on American society. Over 75 leaders recently met at the USA-IT 2025 National Summit to call on Congress for new policies aimed at dismantling the $2.2 trillion underground economy, which encompasses...
Continue Reading